In situ nanoparticle-based drug delivery system to enhance penetration of antifungals through the nail.
State: Looking for partner. Please, contact us if you are interested
- Improved formulations of the two marketed topical antifungals: Ciclopirox and Amorolfine
- Increasing of drug efficacy up to 5 times
- Suitable vehicle for the incorporation of new APIs of interest
- Cost-effective manufacturing
- Intellectual property rights until 2031
More information (PDF, 398 Kb)